Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants

Clotilde Guidetti, George I. Papakostas, Steven Stahl, Luca Pani, Sara De Martin, Andrea Mattarei, Stefano Comai, Cornelia Kröger, Paggard Champasa, Charles W. Gorodetzky, Frank J. Vocci, Thomas R. Kosten, David Bushnell, Martin Kappler, Franco Folli, Charles E. Inturrisi, Marco Pappagallo, Paolo L. Manfredi, Maurizio Fava

Open source

DOI: 10.1097/yic.0000000000000618
Published: 2026-02-17
Container: International Clinical Psychopharmacology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/yic.0000000000000618,
  title = {Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants},
  author = {Clotilde Guidetti and George I. Papakostas and Steven Stahl and Luca Pani and Sara De Martin and Andrea Mattarei and Stefano Comai and Cornelia Kröger and Paggard Champasa and Charles W. Gorodetzky and Frank J. Vocci and Thomas R. Kosten and David Bushnell and Martin Kappler and Franco Folli and Charles E. Inturrisi and Marco Pappagallo and Paolo L. Manfredi and Maurizio Fava},
  year = {2026},
  journal = {International Clinical Psychopharmacology},
  doi = {10.1097/yic.0000000000000618},
  url = {https://doi.org/10.1097/yic.0000000000000618}
}

RIS

TY  - JOUR
TI  - Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants
AU  - Clotilde Guidetti
AU  - George I. Papakostas
AU  - Steven Stahl
AU  - Luca Pani
AU  - Sara De Martin
AU  - Andrea Mattarei
AU  - Stefano Comai
AU  - Cornelia Kröger
AU  - Paggard Champasa
AU  - Charles W. Gorodetzky
AU  - Frank J. Vocci
AU  - Thomas R. Kosten
AU  - David Bushnell
AU  - Martin Kappler
AU  - Franco Folli
AU  - Charles E. Inturrisi
AU  - Marco Pappagallo
AU  - Paolo L. Manfredi
AU  - Maurizio Fava
PY  - 2026
JO  - International Clinical Psychopharmacology
DO  - 10.1097/yic.0000000000000618
UR  - https://doi.org/10.1097/yic.0000000000000618
ER  -

APA

Guidetti, C., Papakostas, G. I., Stahl, S., Pani, L., Martin, S. D., Mattarei, A., Comai, S., Kröger, C., Champasa, P., Gorodetzky, C. W., Vocci, F. J., Kosten, T. R., Bushnell, D., Kappler, M., Folli, F., Inturrisi, C. E., Pappagallo, M., Manfredi, P. L., & Fava, M. (2026). Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000618

Source records

crossref · retrieved 2026-09-26T08:04:07.306Z